Govt plans to boost production of active pharma ingredients

Published On 2015-12-16 08:04 GMT   |   Update On 2015-12-16 08:04 GMT

New Delhi: Terming the import of large quantities of pharmaceutical ingredients from China as "unfortunate", government today said it plans to boost their production in the country.Responding to a question on import of 'interior' quality of active pharmaceutical ingredients from China, Minister of State for Pharmaceuticals and Chemicals Hansraj Gangaram Ahir said it is "unfortunate" that...

Login or Register to read the full article
New Delhi: Terming the import of large quantities of pharmaceutical ingredients from China as "unfortunate", government today said it plans to boost their production in the country.

Responding to a question on import of 'interior' quality of active pharmaceutical ingredients from China, Minister of State for Pharmaceuticals and Chemicals Hansraj Gangaram Ahir said it is "unfortunate" that India continues to import these ingredients from countries like China and six mega parks are also planned in this regard.

He said there are also plans to revive two old plants and steps have already been initiated in this regard.

Responding to a separate question on maximum residue limit of pesticides allowed in food items in the country, Minister of State for Agriculture Sanjay Balyan said in certain cases the limit has not been set for some pesticides but the government is making efforts to ensure that such a limit is decided in the near future.

Pesticide residues on crops are monitored through the use of Maximum Residue Limits, based on the analysis of the quantity of a given chemical remaining on food product samples. NAB ARC
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News